Long-Term Liabilities: The sum of all non-current liabilities.
ENDRA Life Sciences Inc. (NDRA) had Long-Term Liabilities of $0.85M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.04M |
|
-- |
|
-- |
|
$1.47M |
|
$-1.47M |
|
$0.43M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.04M |
|
$-1.47M |
|
$-1.42M |
|
0.56M |
|
0.56M |
|
$-1.86 |
|
$-1.86 |
|
| Balance Sheet Financials | |
$2.18M |
|
$0.07M |
|
$0.99M |
|
$3.17M |
|
$0.57M |
|
-- |
|
|
Long-Term Liabilities |
$0.85M |
$1.42M |
|
$1.75M |
|
$1.75M |
|
$1.75M |
|
0.56M |
|
| Cash Flow Statement Financials | |
$-1.29M |
|
$-0.02M |
|
$0.15M |
|
$3.23M |
|
$2.06M |
|
$-1.16M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-59.12% |
|
-59.12% |
|
-32.69% |
|
-59.12% |
|
$3.12 |
|
$-2.35 |
|
$-2.32 |
|